Logo image of CNR

CORE NATURAL RESOURCES INC (CNR) Stock Fundamental Analysis

NYSE:CNR - New York Stock Exchange, Inc. - US2189371006 - Common Stock - Currency: USD

75.6  +3.21 (+4.43%)

After market: 75.6 0 (0%)

Fundamental Rating

5

Taking everything into account, CNR scores 5 out of 10 in our fundamental rating. CNR was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. CNR has only an average score on both its financial health and profitability. CNR is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CNR had positive earnings in the past year.
In the past year CNR had a positive cash flow from operations.
Of the past 5 years CNR 4 years were profitable.
Each year in the past 5 years CNR had a positive operating cash flow.
CNR Yearly Net Income VS EBIT VS OCF VS FCFCNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

CNR has a Return On Assets of 1.84%. This is comparable to the rest of the industry: CNR outperforms 42.65% of its industry peers.
With a Return On Equity value of 2.96%, CNR perfoms like the industry average, outperforming 40.76% of the companies in the same industry.
CNR has a Return On Invested Capital of 3.20%. This is in the lower half of the industry: CNR underperforms 66.35% of its industry peers.
CNR had an Average Return On Invested Capital over the past 3 years of 24.39%. This is in line with the industry average of 23.79%.
The last Return On Invested Capital (3.20%) for CNR is well below the 3 year average (24.39%), which needs to be investigated, but indicates that CNR had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.84%
ROE 2.96%
ROIC 3.2%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
CNR Yearly ROA, ROE, ROICCNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

CNR's Profit Margin of 4.31% is in line compared to the rest of the industry. CNR outperforms 43.13% of its industry peers.
CNR's Profit Margin has improved in the last couple of years.
The Operating Margin of CNR (7.78%) is worse than 63.98% of its industry peers.
CNR's Operating Margin has improved in the last couple of years.
CNR has a Gross Margin of 23.23%. This is in the lower half of the industry: CNR underperforms 63.98% of its industry peers.
CNR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.78%
PM (TTM) 4.31%
GM 23.23%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
CNR Yearly Profit, Operating, Gross MarginsCNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

CNR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CNR has less shares outstanding
The number of shares outstanding for CNR has been increased compared to 5 years ago.
CNR has a better debt/assets ratio than last year.
CNR Yearly Shares OutstandingCNR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CNR Yearly Total Debt VS Total AssetsCNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CNR has an Altman-Z score of 1.90. This is not the best score and indicates that CNR is in the grey zone with still only limited risk for bankruptcy at the moment.
CNR's Altman-Z score of 1.90 is fine compared to the rest of the industry. CNR outperforms 63.03% of its industry peers.
CNR has a debt to FCF ratio of 4.13. This is a neutral value as CNR would need 4.13 years to pay back of all of its debts.
CNR's Debt to FCF ratio of 4.13 is fine compared to the rest of the industry. CNR outperforms 69.19% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that CNR is not too dependend on debt financing.
The Debt to Equity ratio of CNR (0.08) is better than 78.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 4.13
Altman-Z 1.9
ROIC/WACC0.33
WACC9.57%
CNR Yearly LT Debt VS Equity VS FCFCNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CNR has a Current Ratio of 1.89. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CNR (1.89) is better than 75.83% of its industry peers.
A Quick Ratio of 1.34 indicates that CNR should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.34, CNR is doing good in the industry, outperforming 68.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.34
CNR Yearly Current Assets VS Current LiabilitesCNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

7

3. Growth

3.1 Past

CNR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -63.31%.
Measured over the past years, CNR shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.60% on average per year.
CNR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.42%.
The Revenue has been growing by 9.16% on average over the past years. This is quite good.
EPS 1Y (TTM)-63.31%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-105.01%
Revenue 1Y (TTM)10.42%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%83.33%

3.2 Future

The Earnings Per Share is expected to grow by 9.84% on average over the next years. This is quite good.
CNR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.32% yearly.
EPS Next Y-42.14%
EPS Next 2Y12.43%
EPS Next 3Y10.96%
EPS Next 5Y9.84%
Revenue Next Year74.21%
Revenue Next 2Y38.85%
Revenue Next 3Y24.32%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNR Yearly Revenue VS EstimatesCNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
CNR Yearly EPS VS EstimatesCNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

CNR is valuated correctly with a Price/Earnings ratio of 12.50.
Based on the Price/Earnings ratio, CNR is valued a bit cheaper than the industry average as 62.09% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CNR to the average of the S&P500 Index (27.30), we can say CNR is valued rather cheaply.
With a Price/Forward Earnings ratio of 6.22, the valuation of CNR can be described as very cheap.
Based on the Price/Forward Earnings ratio, CNR is valued cheaply inside the industry as 88.63% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CNR to the average of the S&P500 Index (21.76), we can say CNR is valued rather cheaply.
Industry RankSector Rank
PE 12.5
Fwd PE 6.22
CNR Price Earnings VS Forward Price EarningsCNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CNR.
CNR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 44.83
EV/EBITDA 7.98
CNR Per share dataCNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.55
EPS Next 2Y12.43%
EPS Next 3Y10.96%

2

5. Dividend

5.1 Amount

CNR has a yearly dividend return of 0.97%, which is pretty low.
CNR's Dividend Yield is slightly below the industry average, which is at 6.48.
With a Dividend Yield of 0.97, CNR pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 0.97%

5.2 History

CNR has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNR Yearly Dividends per shareCNR Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CNR pays out 22.54% of its income as dividend. This is a sustainable payout ratio.
DP22.54%
EPS Next 2Y12.43%
EPS Next 3Y10.96%
CNR Yearly Income VS Free CF VS DividendCNR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
CNR Dividend Payout.CNR Dividend Payout, showing the Payout Ratio.CNR Dividend Payout.PayoutRetained Earnings

CORE NATURAL RESOURCES INC

NYSE:CNR (7/11/2025, 8:04:00 PM)

After market: 75.6 0 (0%)

75.6

+3.21 (+4.43%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners92.1%
Inst Owner Change0%
Ins Owners1.83%
Ins Owner Change15.76%
Market Cap3.98B
Analysts77.5
Price Target94.86 (25.48%)
Short Float %6.54%
Short Ratio3.94
Dividend
Industry RankSector Rank
Dividend Yield 0.97%
Yearly Dividend0.53
Dividend Growth(5Y)N/A
DP22.54%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-30 2025-05-30 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-86.03%
Min EPS beat(2)-110.49%
Max EPS beat(2)-61.58%
EPS beat(4)2
Avg EPS beat(4)-21.33%
Min EPS beat(4)-110.49%
Max EPS beat(4)86%
EPS beat(8)5
Avg EPS beat(8)-9.02%
EPS beat(12)9
Avg EPS beat(12)9.18%
EPS beat(16)11
Avg EPS beat(16)-22.39%
Revenue beat(2)1
Avg Revenue beat(2)-10.94%
Min Revenue beat(2)-24.65%
Max Revenue beat(2)2.77%
Revenue beat(4)3
Avg Revenue beat(4)-0.94%
Min Revenue beat(4)-24.65%
Max Revenue beat(4)15.41%
Revenue beat(8)6
Avg Revenue beat(8)1.63%
Revenue beat(12)10
Avg Revenue beat(12)7.59%
Revenue beat(16)13
Avg Revenue beat(16)8.77%
PT rev (1m)-4.45%
PT rev (3m)-16.03%
EPS NQ rev (1m)-34.3%
EPS NQ rev (3m)-27.56%
EPS NY rev (1m)-37.51%
EPS NY rev (3m)-41.83%
Revenue NQ rev (1m)2.94%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)0.53%
Revenue NY rev (3m)-2.61%
Valuation
Industry RankSector Rank
PE 12.5
Fwd PE 6.22
P/S 1.49
P/FCF 44.83
P/OCF 13.76
P/B 1.02
P/tB 1.02
EV/EBITDA 7.98
EPS(TTM)6.05
EY8%
EPS(NY)12.15
Fwd EY16.07%
FCF(TTM)1.69
FCFY2.23%
OCF(TTM)5.49
OCFY7.27%
SpS50.75
BVpS73.98
TBVpS73.98
PEG (NY)N/A
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 1.84%
ROE 2.96%
ROCE 3.75%
ROIC 3.2%
ROICexc 3.44%
ROICexgc 3.44%
OM 7.78%
PM (TTM) 4.31%
GM 23.23%
FCFM 3.32%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
ROICexc(3y)28.23%
ROICexc(5y)18.22%
ROICexgc(3y)28.23%
ROICexgc(5y)N/A
ROCE(3y)28.54%
ROCE(5y)18.52%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y35.93%
ROICexc growth 5Y15.67%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 4.13
Debt/EBITDA 0.66
Cap/Depr 69.58%
Cap/Sales 7.5%
Interest Coverage 250
Cash Conversion 58.32%
Profit Quality 77.07%
Current Ratio 1.89
Quick Ratio 1.34
Altman-Z 1.9
F-Score6
WACC9.57%
ROIC/WACC0.33
Cap/Depr(3y)74.91%
Cap/Depr(5y)64.93%
Cap/Sales(3y)7.37%
Cap/Sales(5y)8.18%
Profit Quality(3y)104.03%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-63.31%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-105.01%
EPS Next Y-42.14%
EPS Next 2Y12.43%
EPS Next 3Y10.96%
EPS Next 5Y9.84%
Revenue 1Y (TTM)10.42%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%83.33%
Revenue Next Year74.21%
Revenue Next 2Y38.85%
Revenue Next 3Y24.32%
Revenue Next 5YN/A
EBIT growth 1Y-66.77%
EBIT growth 3Y34.19%
EBIT growth 5Y12.15%
EBIT Next Year52.44%
EBIT Next 3Y34.78%
EBIT Next 5Y22.8%
FCF growth 1Y-84.76%
FCF growth 3Y19.97%
FCF growth 5Y31.85%
OCF growth 1Y-61.5%
OCF growth 3Y15.95%
OCF growth 5Y14.26%